top of page

ALS & Paralysis

Exploring iPSC-derived cell therapies for ALS and paralysis.

  • 2 hours
  • 8,500 US dollars

Service Description

iPSC technology may enable the generation of motor neurons and supporting cells that could potentially replace those lost or dysfunctional in ALS. However, more research is still needed to fully evaluate the safety and efficacy of such cell therapies for ALS and paralysis.

bottom of page